247 related articles for article (PubMed ID: 38284661)
1. Updated German guideline on diagnosis and treatment of squamous cell carcinoma and adenocarcinoma of the esophagus.
Porschen R; Fischbach W; Gockel I; Hollerbach S; Hölscher A; Jansen PL; Miehlke S; Pech O; Stahl M; Vanhoefer U; Ebert MPA
United European Gastroenterol J; 2024 Apr; 12(3):399-411. PubMed ID: 38284661
[TBL] [Abstract][Full Text] [Related]
2. [New S3 guideline for esophageal cancer : Important surgical aspects].
Hölscher AH; Stahl M; Messmann H; Stuschke M; Meyer HJ; Porschen R
Chirurg; 2016 Oct; 87(10):865-72. PubMed ID: 27406251
[TBL] [Abstract][Full Text] [Related]
3. [Current diagnosis and therapy of esophageal carcinoma].
Mühr-Wilkenshoff F; Stahl M; Faiss S; Zeitz M; Scherübl H
Z Gastroenterol; 2004 Jul; 42(7):615-21. PubMed ID: 15248111
[TBL] [Abstract][Full Text] [Related]
4. International comparison of the German evidence-based S3-guidelines on the diagnosis and multimodal treatment of early and locally advanced gastric cancer, including adenocarcinoma of the lower esophagus.
Moehler M; Baltin CT; Ebert M; Fischbach W; Gockel I; Grenacher L; Hölscher AH; Lordick F; Malfertheiner P; Messmann H; Meyer HJ; Palmqvist A; Röcken C; Schuhmacher C; Stahl M; Stuschke M; Vieth M; Wittekind C; Wagner D; Mönig SP
Gastric Cancer; 2015 Jul; 18(3):550-63. PubMed ID: 25192931
[TBL] [Abstract][Full Text] [Related]
5. New therapeutic strategies for squamous cell cancer and adenocarcinoma.
Wijnhoven BPL; Toxopeus ELA; Vallböhmer D; Knoefel WT; Krasna MJ; Perez K; van Rossum PSN; Ruurda JP; van Hillegersberg R; Schiesser M; Schneider P; Felix VN
Ann N Y Acad Sci; 2013 Oct; 1300():213-225. PubMed ID: 24117644
[TBL] [Abstract][Full Text] [Related]
6. Impact of ABCB1 C3435T polymorphism on lymph node regression in multimodality treatment of locally advanced esophageal cancer.
Narumiya K; Metzger R; Bollschweiler E; Alakus H; Brabender J; Drebber U; Hölscher AH; Warnecke-Eberz U
Pharmacogenomics; 2011 Feb; 12(2):205-14. PubMed ID: 21332314
[TBL] [Abstract][Full Text] [Related]
7. Management of Patients With Adenocarcinoma or Squamous Cancer of the Esophagus.
Ilson DH; van Hillegersberg R
Gastroenterology; 2018 Jan; 154(2):437-451. PubMed ID: 29037469
[TBL] [Abstract][Full Text] [Related]
8. CMISG1701: a multicenter prospective randomized phase III clinical trial comparing neoadjuvant chemoradiotherapy to neoadjuvant chemotherapy followed by minimally invasive esophagectomy in patients with locally advanced resectable esophageal squamous cell carcinoma (cT
Tang H; Tan L; Shen Y; Wang H; Lin M; Feng M; Xu S; Guo W; Qian C; Liu T; Zeng Z; Hou Y; Yu Z; Jiang H; Li Z; Chen C; Lian C; Du M; Li H; Xie D; Yin J; Zhao N; Wang Q
BMC Cancer; 2017 Jun; 17(1):450. PubMed ID: 28659128
[TBL] [Abstract][Full Text] [Related]
9. Synchronous triple primary cancers of the pharynx and esophagus.
Kataoka S; Omae M; Horiuchi Y; Ishiyama A; Yoshio T; Hirasawa T; Yamamoto Y; Tsuchida T; Fujisaki J; Yamada K; Igarashi M
Clin J Gastroenterol; 2017 Jun; 10(3):208-213. PubMed ID: 28315155
[TBL] [Abstract][Full Text] [Related]
10. [Barrett's esophagus carcinoma].
Messmann H
Praxis (Bern 1994); 2006 Jun; 95(25-26):1029-35. PubMed ID: 16836063
[TBL] [Abstract][Full Text] [Related]
11. Nodal metastasis from locally advanced esophageal cancer: how neoadjuvant therapy modifies their frequency and distribution.
Castoro C; Scarpa M; Cagol M; Ruol A; Cavallin F; Alfieri R; Zanchettin G; Rugge M; Ancona E
Ann Surg Oncol; 2011 Dec; 18(13):3743-54. PubMed ID: 21556952
[TBL] [Abstract][Full Text] [Related]
12. [Chemotherapy and Radio-Chemotherapy of Locally Advanced Esophageal Cancer].
Wille K; Mann C; Berlth F; Fetzner UK; Othmann K; Mönig SP
Ther Umsch; 2022 Apr; 79(3-4):189-194. PubMed ID: 35440193
[TBL] [Abstract][Full Text] [Related]
13. Radiotherapy in the multimodality management of esophageal cancer.
Encheva E; Kolev N; Tonev A; Ignatov V; Shterev S; Petrov D; Zlatarov A; Koleva I; Chaushev B; Kirilova T; Ivanov K
Khirurgiia (Sofiia); 2014; (3):12-9. PubMed ID: 25799618
[TBL] [Abstract][Full Text] [Related]
14. Effects of neoadjuvant radiochemotherapy on pathological staging and prognosis for locally advanced esophageal squamous cell carcinoma.
Cao XF; He XT; Ji L; Xiao J; Lv J
Dis Esophagus; 2009; 22(6):477-81. PubMed ID: 19703071
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant (postoperative) therapy for esophageal cancer.
Ku GY; Ilson DH
Thorac Surg Clin; 2013 Nov; 23(4):525-33. PubMed ID: 24199702
[TBL] [Abstract][Full Text] [Related]
16. Management of advanced-stage operable esophageal cancer.
Bharat A; Crabtree T
Surg Clin North Am; 2012 Oct; 92(5):1179-97. PubMed ID: 23026277
[TBL] [Abstract][Full Text] [Related]
17. Gastroesophageal junction adenocarcinoma.
Swisher SG; Pisters PW; Komaki R; Lahoti S; Ajani JA
Curr Treat Options Oncol; 2000 Dec; 1(5):387-98. PubMed ID: 12057146
[TBL] [Abstract][Full Text] [Related]
18. [Staging and neoadjuvant therapy of squamous cell carcinoma of esophagus].
Benhidjeb T; Moesta KT; Schlag PM
Ther Umsch; 2001 Mar; 58(3):165-73. PubMed ID: 11305155
[TBL] [Abstract][Full Text] [Related]
19. Esophageal Cancer: New Insights into a Heterogenous Disease.
Krug S; Michl P
Digestion; 2017; 95(4):253-261. PubMed ID: 28384630
[TBL] [Abstract][Full Text] [Related]
20. Multimodal treatment of esophageal cancer.
Lordick F; Hölscher AH; Haustermans K; Wittekind C
Langenbecks Arch Surg; 2013 Feb; 398(2):177-87. PubMed ID: 22971784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
